Eypt stock

EYPT’s stock has fallen by -14.70% in the past week, with a monthly rise of 45.86% and a quarterly rise of 48.40%. The volatility ratio for the week is 9.79% while the volatility levels for the last 30 days are 10.13% for EyePoint Pharmaceuticals Inc.Overview Stock Screener Earnings Calendar Sectors Nasdaq | EYPT U.S.: Nasdaq EyePoint Pharmaceuticals Inc. Watch list After Hours Last Updated: Sep 1, 2023 7:37 p.m. EDT Delayed quote $ 10.50...Stock Market Index for Egypt from The World Bank for the Global Economic Monitor release. This page provides forecast and historical data, charts, statistics, news and updates for Egypt Stock Market Index.Get Telecom Egypt Co SAE (ETEL.CA) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe EyePoint Pharmaceuticals Inc. stock price fell by -0.298% on the last day (Friday, 8th Sep 2023) from $10.06 to $10.03. During the last trading day the stock fluctuated 5.33% from a day low at $9.76 to a day high of $10.28. The price has been going up and down for this period, and there has been a -12.86% loss for the last 2 weeks.Market capitalization shows the value of a corporation by multiplying the stock price by the number of stocks outstanding. Here you can see the companies with the largest market cap. Large-cap stocks are usually industry and sector leaders and represent well-known, established companies. Balance Sheet. Cash Flow. 11.7180. -0.0363. -0.31%. -42.88%. Sep/07. Egyptian Pound. The USDEGP spot exchange rate specifies how much one currency, the USD, is currently worth in terms of the other, the EGP. While the USDEGP spot exchange rate is quoted and exchanged in the same day, the USDEGP forward rate is quoted today but for delivery and payment on a specific ...The latest price target for EyePoint Pharmaceuticals ( NASDAQ: EYPT) was reported by HC Wainwright & Co. on Thursday, August 3, 2023. The analyst firm set a price target for 27.00 expecting EYPT ... Jan 17, 2023 · Eyepoint Pharmaceuticals Inc is down 11.9% from its previous closing price of $5.04. Before the stock market closed, Eyepoint Pharmaceuticals Inc’s stock traded between $4.93 and $5.80. Currently, there are 37.34 million shares of Eyepoint Pharmaceuticals Inc stock available for purchase. Unfortunately, Eyepoint Pharmaceuticals Inc’s P/E ... After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ... As of 2023 September 12, Tuesday current price of EYPT stock is 11.640$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). EyePoint Pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame.EyePoint Pharmaceuticals (EYPT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts... EYPT : 11.51 (-1.12%) EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Tops Revenue Estimates Zacks - Thu Mar 2, 8:55AM CST.Overview Key Ratios Trading Information Last Close 9.44 Sector Healthcare Industry Biotechnology Investment Style Small Growth Day Range 9.17 – 10.39 Year Range 2.19 – 15.63 Market Cap 330.2494 Mil...Sep 5, 2023 · Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for EYPT stock stock is $32.2, which predicts an increase of 241.10%. The lowest target is $22 and the highest is $55. On average, analysts rate EYPT stock stock as a strong buy. For EyePoint Pharmaceuticals stock forecast for 2023, 3 predictions are offered for each month of 2023 with average EyePoint Pharmaceuticals stock forecast of $12.57, a high forecast of $13.84, and a low forecast of $11.22. The average EyePoint Pharmaceuticals stock forecast 2023 represents a 25.36% increase from the last price of $10. ... Sep 4, 2023 · The average trading volume of EYPT on September 04, 2023 was 588.48K shares. EYPT) stock’s latest price update. The stock of EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) has increased by 6.16 when compared to last closing price of 9.91. Despite this, the company has experienced a -6.98% fall in its stock price over the last five trading sessions. You can find your newly purchased EYPT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets. EyePoint Pharmaceuticals Stock Earnings The value each EYPT share was expected to gain vs. the value that each EYPT share actually gained.Feb 16, 2010 · VanEck Egypt Index ETF (EGPT ® ) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS ® Egypt Index (MVEGPTTR), which includes securities of companies that are incorporated in Egypt or that are incorporated outside Egypt but have at least 50% of their revenues/related assets in Egypt. Sep 13, 2023 · EYPT Earnings Date and Information. EyePoint Pharmaceuticals last released its quarterly earnings data on August 2nd, 2023. The reported ($0.61) EPS for the quarter, missing the consensus estimate of $0.41 by $1.02. The firm earned $9.11 million during the quarter, compared to analysts' expectations of $79.03 million. According to the issued ratings of 5 analysts in the last year, the consensus rating for EyePoint Pharmaceuticals stock is Buy based on the current 5 buy ratings for EYPT. The average twelve-month price prediction for EyePoint Pharmaceuticals is $33.00 with a high price target of $52.00 and a low price target of $22.00.Feb 16, 2010 · VanEck Egypt Index ETF (EGPT ® ) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS ® Egypt Index (MVEGPTTR), which includes securities of companies that are incorporated in Egypt or that are incorporated outside Egypt but have at least 50% of their revenues/related assets in Egypt. Get Telecom Egypt Co SAE (ETEL.CA) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSep 11, 2023 · The EyePoint Pharmaceuticals Inc. stock price fell by -0.298% on the last day (Friday, 8th Sep 2023) from $10.06 to $10.03. During the last trading day the stock fluctuated 5.33% from a day low at $9.76 to a day high of $10.28. The price has been going up and down for this period, and there has been a -12.86% loss for the last 2 weeks. Feb 16, 2010 · VanEck Egypt Index ETF (EGPT ® ) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS ® Egypt Index (MVEGPTTR), which includes securities of companies that are incorporated in Egypt or that are incorporated outside Egypt but have at least 50% of their revenues/related assets in Egypt. Apr 21, 2023 · These Healthcare stocks are trading higher: -Mangoceuticals Inc ( MGRX) stock is trading at $2.49, an increase of $1.56, or 166.42%, on high volume. Mangoceuticals Inc gets a Sentiment Score of Bearish from InvestorsObserver. -Onconova Therapeutics Inc ( ONTX) stock is trading at $1.11, a gain of $0.4, or 57.63%, on high volume. google play movies and tv
Jan 17, 2023 · Eyepoint Pharmaceuticals Inc is down 11.9% from its previous closing price of $5.04. Before the stock market closed, Eyepoint Pharmaceuticals Inc’s stock traded between $4.93 and $5.80. Currently, there are 37.34 million shares of Eyepoint Pharmaceuticals Inc stock available for purchase. Unfortunately, Eyepoint Pharmaceuticals Inc’s P/E ... Sep 13, 2023 · A list of analyst ratings for EyePoint Pharmaceuticals (EYPT) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. 2 days ago · JonesTrading Initiates EyePoint Pharmaceuticals at Buy With $26 Price Target. Jun. 14. MT. Chardan Raises Price Target on EyePoint Pharmaceuticals to $22 From $21, Keeps Buy Rating. May. 19. MT. HC Wainwright Adjusts Price Target on EyePoint Pharmaceuticals to $27 From $25, Keeps Buy Rating. May. 19. EyePoint Pharmaceuticals (EYPT) Quote Overview » Zacks Research » EyePoint Pharmaceuticals (EYPT) Style Scores. EYEPOINT PHARMACEUTICALS, INC. - Hold. Zacks' proprietary data indicates that ...EyePoint Pharmaceuticals (EYPT) has 1 split in our EYPT split history database. The split for EYPT took place on December 09, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of EYPT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. Overview Stock Screener Earnings Calendar Sectors Nasdaq | EYPT U.S.: Nasdaq EyePoint Pharmaceuticals Inc. Watch list After Hours Last Updated: Sep 1, 2023 7:37 p.m. EDT Delayed quote $ 10.50... Find the latest EyePoint Pharmaceuticals, Inc. (EYPT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. EyePoint Pharmaceuticals (NASDAQ:EYPT) adds US$32m to market cap in the past 7 days, though investors from five years ago are still down 55%. (Simply Wall St.) May-18-22 11:03AM. Horizon (HZNP) Begins Enrollment in Alopecia Areata Study.militaryonesource
For EyePoint Pharmaceuticals stock forecast for 2023, 3 predictions are offered for each month of 2023 with average EyePoint Pharmaceuticals stock forecast of $12.57, a high forecast of $13.84, and a low forecast of $11.22. The average EyePoint Pharmaceuticals stock forecast 2023 represents a 25.36% increase from the last price of $10. ... Apr 25, 2023 · EYPT stock closed at $7.76 and is down -$0.57 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. EYPT has a strong overall score of 78 meaning the stock holds a better value than 78% of stocks at its current price. Sep 12, 2023 · View EYEPOINT PHARMACEUTICALS, INC EYPT investment & stock information. Get the latest EYEPOINT PHARMACEUTICALS, INC EYPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. EyePoint Pharmaceuticals (NASDAQ:EYPT) adds US$32m to market cap in the past 7 days, though investors from five years ago are still down 55%. (Simply Wall St.) May-18-22 11:03AM. Horizon (HZNP) Begins Enrollment in Alopecia Areata Study. EyePoint Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time EYPT stock price.EyePoint Pharmaceuticals, Inc. focuses on developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The company's pipeline leverages its proprietary erodible Durasert E technology for sustained intraocular drug delivery, including EYP-1901, an investigational sustained delivery intravitreal ...Sep 14, 2023 · Get EyePoint Pharmaceuticals Inc (EYPT.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments EyePoint Pharmaceuticals (EYPT) Quote Overview » Zacks Research » EyePoint Pharmaceuticals (EYPT) Style Scores. EYEPOINT PHARMACEUTICALS, INC. - Hold. Zacks' proprietary data indicates that ...EYPT acquired privately-held Icon Bioscience, Inc. and its FDA approved product, DEXYCU™. DEXYCU was approved by the FDA on February 9, 2018, for the treatment of postoperative inflammation and ...EYPT stock is up 18.6% as of Monday morning. There’s more stock market news to sink your teeth into below! InvestorPlace has all the latest stock coverage that traders need to know about.For EyePoint Pharmaceuticals stock forecast for 2023, 3 predictions are offered for each month of 2023 with average EyePoint Pharmaceuticals stock forecast of $12.57, a high forecast of $13.84, and a low forecast of $11.22. The average EyePoint Pharmaceuticals stock forecast 2023 represents a 25.36% increase from the last price of $10. ...JonesTrading Initiates EyePoint Pharmaceuticals at Buy With $26 Price Target. Jun. 14. MT. Chardan Raises Price Target on EyePoint Pharmaceuticals to $22 From $21, Keeps Buy Rating. May. 19. MT. HC Wainwright Adjusts Price Target on EyePoint Pharmaceuticals to $27 From $25, Keeps Buy Rating. May. 19.lillypad
News EyePoint Pharmaceuticals Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.83 Market Cap $341.79 M Shares Outstanding 34.98 M Public...Most stock quote data provided by BATS. US market indices are shown in real time, except for the S&P 500 which is refreshed every two minutes. All times are ET. Factset: FactSet Research Systems Inc.Market capitalization shows the value of a corporation by multiplying the stock price by the number of stocks outstanding. Here you can see the companies with the largest market cap. Large-cap stocks are usually industry and sector leaders and represent well-known, established companies. Balance Sheet. Cash Flow. Conclusion. Under the original buffett indicator, the stock market of Egypt is expected to return 17.4% a year for the coming years. This is from the contribution of economic growth in local current prices: 11.86%, Dividend Yield: 2.43% and valuation reverse to the mean 3.14%. Under the modified model, the contribution of economic growth and ...EYPT stock is up 18.6% as of Monday morning. There’s more stock market news to sink your teeth into below! InvestorPlace has all the latest stock coverage that traders need to know about.Overview Stock Screener Earnings Calendar Sectors Nasdaq | EYPT U.S.: Nasdaq EyePoint Pharmaceuticals Inc. Watch list After Hours Last Updated: Sep 1, 2023 7:37 p.m. EDT Delayed quote $ 10.50...According to 5 analysts, the average rating for EYPT stock is "Strong Buy." The 12-month stock price forecast is $32.2, which is an increase of 221.04% from the latest price. Price TargetNASDAQ Health Care/Life Sciences Compare to Open 9.88 Prior Close 9.91 (08/31/23) 1 Day EYPT 6.16% DJIA 0.33% Russell 2K 1.11% Health Care/Life Sciences 0.31% Overview to Discover historical prices for EYPT stock on Yahoo Finance. View daily, weekly or monthly format back to when EyePoint Pharmaceuticals, Inc. stock was issued. Sep 5, 2023 · Overview Key Ratios Trading Information Last Close 9.44 Sector Healthcare Industry Biotechnology Investment Style Small Growth Day Range 9.17 – 10.39 Year Range 2.19 – 15.63 Market Cap 330.2494 Mil... Get the latest EyePoint Pharmaceuticals, Inc. (EYPT) stock news and headlines to help you in your trading and investing decisions. Home; Mail; News; ... EyePoint Pharmaceuticals (EYPT) delivered ... The public float for EYPT is 31.41M and currently, short sellers hold a 16.09% ratio of that float. The average trading volume of EYPT on September 12, 2023 was 595.61K shares. EYPT’s Market Performance. EYPT stock saw a decrease of 10.74% in the past week, with a monthly decline of -16.90% and a quarterly a decrease of 92.56%.Sep 13, 2023 · A list of analyst ratings for EyePoint Pharmaceuticals (EYPT) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. barbie the princess and the popstar
EyePoint Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target EYPT. High $ 55.00: Median $ 30.00: Low $ 22.00: Average $ 31.75 ...Jan 11, 2023 · (See EYPT stock forecast) Alpha Tau Medical, Ltd. ( DRTS ) Next up is Alpha Tau Medical, a biotech company working on new modes of focal alpha-radiation treatment for various cancers. Up-to-date data on the stock market in Egypt, including leading stocks, large and small cap stocks.Eyepoint Pharmaceuticals Inc (EYPT) Stock Price & News - Google Finance Markets Dow Jones 34,576.59 +75.86 4,457.49 +0.14% +6.35 13,761.52 +0.092% 1,851.54 -0.23% -4.21 Home EYPT • NASDAQ... EyePoint Pharmaceuticals (EYPT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts... EYPT : 11.51 (-1.12%) EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Tops Revenue Estimates Zacks - Thu Mar 2, 8:55AM CST.Jan 11, 2023 · (See EYPT stock forecast) Alpha Tau Medical, Ltd. ( DRTS ) Next up is Alpha Tau Medical, a biotech company working on new modes of focal alpha-radiation treatment for various cancers. As of 2023 September 12, Tuesday current price of EYPT stock is 11.640$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). EyePoint Pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame.The 8 analysts offering 1 year price forecasts for EYPT have a max estimate of — and a min estimate of —. Analyst rating Based on 8 analysts giving stock ratings to EYPT in the past 3 months. What's Happening With EYPT Stock Today? To screen for more stocks like Eyepoint Pharmaceuticals Inc click here. More About Eyepoint Pharmaceuticals Inc EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases.Aug 30, 2023 · Its Peers: A Comparison. Additionally, the 36-month beta value for EYPT is 1.32. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price predicted by analysts for EYPT is $31.75, which is $21.25 above the ... EYPT stock is up 18.6% as of Monday morning. There’s more stock market news to sink your teeth into below! InvestorPlace has all the latest stock coverage that traders need to know about.EYPT’s Market Performance. EyePoint Pharmaceuticals Inc. (EYPT) has seen a 11.89% rise in stock performance for the week, with a 51.57% gain in the past month and a 109.57% surge in the past quarter. The volatility ratio for the week is 9.31%, and the volatility levels for the past 30 days are at 9.26% for EYPT.Mubasher Info Egypt. Beltone suffers higher net losses in H1-23. Pharmaconex 2023 concludes in Egypt; Informa Markets to take event abroad for 1st time. Network eyes SAMA’s nod to for regional expansion – Al Dahmash in interview at Seamless. OneCard plans to expand in over 22 countries – CEO in interview at Seamless.The latest price target for EyePoint Pharmaceuticals ( NASDAQ: EYPT) was reported by HC Wainwright & Co. on Thursday, August 3, 2023. The analyst firm set a price target for 27.00 expecting EYPT ... nist 800 171EyePoint Pharmaceuticals (NASDAQ:EYPT) has observed the following analyst ratings within the last quarter: These 6 analysts have an average price target of $31.33 versus the current price of ...Sep 14, 2023 · Get EyePoint Pharmaceuticals Inc (EYPT.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Sep 8, 2023 · Analyst Forecast. According to 5 analysts, the average rating for EYPT stock is "Strong Buy." The 12-month stock price forecast is $32.2, which is an increase of 221.04% from the latest price. According to the issued ratings of 5 analysts in the last year, the consensus rating for EyePoint Pharmaceuticals stock is Buy based on the current 5 buy ratings for EYPT. The average twelve-month price prediction for EyePoint Pharmaceuticals is $33.00 with a high price target of $52.00 and a low price target of $22.00.According to 5 stock analysts, the average 12-month stock price forecast for EYPT stock stock is $32.2, which predicts an increase of 241.10%. The lowest target is $22 and the highest is $55. On average, analysts rate EYPT stock stock as a strong buy.The stock price for . EyePoint Pharmaceuticals (NASDAQ: EYPT) is $14.2 last updated August 11, 2023 at 8:00 PM UTC. Q Does EyePoint Pharmaceuticals (EYPT) pay a dividend?Find real-time EYPT - EyePoint Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.Overview Key Ratios Trading Information Last Close 9.44 Sector Healthcare Industry Biotechnology Investment Style Small Growth Day Range 9.17 – 10.39 Year Range 2.19 – 15.63 Market Cap 330.2494 Mil...iStock has a collection of almost 220000 Egypt stock photos including closeup images of camels and Red Sea clownfish as well as stock imagery o Egypt dishes like the egg and tomato stew shakshuka. Our easy-to-search library also features high-quality photos of Egyptian landmarks like the Giza Pyramids and the Sphinx boats travelling the Nile ...Sep 11, 2023 · The EyePoint Pharmaceuticals Inc. stock price fell by -0.298% on the last day (Friday, 8th Sep 2023) from $10.06 to $10.03. During the last trading day the stock fluctuated 5.33% from a day low at $9.76 to a day high of $10.28. The price has been going up and down for this period, and there has been a -12.86% loss for the last 2 weeks. Sep 13, 2023 · A list of analyst ratings for EyePoint Pharmaceuticals (EYPT) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. According to the issued ratings of 5 analysts in the last year, the consensus rating for EyePoint Pharmaceuticals stock is Buy based on the current 5 buy ratings for EYPT. The average twelve-month price prediction for EyePoint Pharmaceuticals is $33.00 with a high price target of $52.00 and a low price target of $22.00.3.6movies
Jun 25, 2018 · EYPT acquired privately-held Icon Bioscience, Inc. and its FDA approved product, DEXYCU™. DEXYCU was approved by the FDA on February 9, 2018, for the treatment of postoperative inflammation and ... Discover historical prices for EYPT stock on Yahoo Finance. View daily, weekly or monthly format back to when EyePoint Pharmaceuticals, Inc. stock was issued. Find the latest EyePoint Pharmaceuticals, Inc. (EYPT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. View the latest Elsewedy Electric (SWDY) stock price, news, historical charts, analyst ratings and financial information from WSJ. EYPT stock is up 18.6% as of Monday morning. There’s more stock market news to sink your teeth into below! InvestorPlace has all the latest stock coverage that traders need to know about.According to the issued ratings of 5 analysts in the last year, the consensus rating for EyePoint Pharmaceuticals stock is Buy based on the current 5 buy ratings for EYPT. The average twelve-month price prediction for EyePoint Pharmaceuticals is $33.00 with a high price target of $52.00 and a low price target of $22.00.EYPT’s Market Performance. EyePoint Pharmaceuticals Inc. (EYPT) has seen a 11.89% rise in stock performance for the week, with a 51.57% gain in the past month and a 109.57% surge in the past quarter. The volatility ratio for the week is 9.31%, and the volatility levels for the past 30 days are at 9.26% for EYPT.Eyepoint Pharmaceuticals Inc (EYPT) Stock Price & News - Google Finance Markets Dow Jones 34,576.59 +75.86 4,457.49 +0.14% +6.35 13,761.52 +0.092% 1,851.54 -0.23% -4.21 Home EYPT • NASDAQ... twn communications
Sep 13, 2023 · EYPT Earnings Date and Information. EyePoint Pharmaceuticals last released its quarterly earnings data on August 2nd, 2023. The reported ($0.61) EPS for the quarter, missing the consensus estimate of $0.41 by $1.02. The firm earned $9.11 million during the quarter, compared to analysts' expectations of $79.03 million. Up-to-date data on the stock market in Egypt, including leading stocks, large and small cap stocks. Sep 13, 2023 · EYPT Earnings Date and Information. EyePoint Pharmaceuticals last released its quarterly earnings data on August 2nd, 2023. The reported ($0.61) EPS for the quarter, missing the consensus estimate of $0.41 by $1.02. The firm earned $9.11 million during the quarter, compared to analysts' expectations of $79.03 million. EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, an investigational ...JonesTrading Initiates EyePoint Pharmaceuticals at Buy With $26 Price Target. Jun. 14. MT. Chardan Raises Price Target on EyePoint Pharmaceuticals to $22 From $21, Keeps Buy Rating. May. 19. MT. HC Wainwright Adjusts Price Target on EyePoint Pharmaceuticals to $27 From $25, Keeps Buy Rating. May. 19.